Assessing the impact of a safe and equitable biosimilar policy in the United States : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, May 2, 2007 |
Descrizione fisica | 1 online resource (vi, 184 p.) : ill |
Soggetto topico |
Biologicals - United States
Pharmaceutical biotechnology - United States Generic drugs - United States |
Soggetto non controllato |
Biologicals
Pharmaceutical biotechnology Generic drugs Medical Technology & engineering |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Assessing the Impact of a Safe and Equitable Biosimilar Policy in the United States |
Record Nr. | UNINA-9910694419603321 |
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Safe and affordable biotech drugs : the need for a generic pathway : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, first session, March 26, 2007 |
Descrizione fisica | 1 online resource (iv, 274 p.) : ill |
Soggetto topico |
Biologicals - United States
Pharmaceutical biotechnology - United States Generic drugs - United States |
Soggetto non controllato |
Biologicals
Pharmaceutical biotechnology Generic drugs Medical Technology & engineering |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Safe and affordable biotech drugs |
Record Nr. | UNINA-9910694411303321 |
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|